AnalystsAndres MaldonadoAndres Maldonado's Stock Forecasts
AnalystsAndres Maldonado
Sectors:
Industries:
Analyst Ranking
Top 14%
#613 out of 4554 analysts
Average Return
+23.77%
Win Rate
41%14 out of 34
Risk vs Reward
Poor
Good
Andres Maldonado's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Werewolf Therapeutics IncHOWL | +180.18% | $2.17 | $6.08 | 2023-03-22 - 2024-03-22 | Buy |
Werewolf Therapeutics IncHOWL | +166.82% | $2.20 | $5.87 | 2023-11-14 - 2024-04-18 | Buy |
Werewolf Therapeutics IncHOWL | +134.80% | $2.50 | $5.87 | 2023-10-30 - 2024-04-18 | Buy |
Werewolf Therapeutics IncHOWL | +131.10% | $2.54 | $5.87 | 2023-09-18 - 2024-04-18 | Buy |
Werewolf Therapeutics IncHOWL | +128.40% | $2.57 | $5.87 | 2023-09-14 - 2024-04-18 | Buy |
Andres Maldonado Analyst Color
Get additional color on Andres Maldonado's coverage of popular stocks
Andres Maldonado's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cg Oncology IncCGON | 2 | Buy | $75.00 | +112.34% | Reiterates | 15 days ago |
Erasca IncERAS | 3 | Buy | $8.00 | +346.93% | Reiterates | 22 days ago |
Scholar Rock Holding CorpSRRK | 6 | Buy | $30.00 | +115.05% | Reiterates | a month ago |
Ikena Oncology IncIKNA | 8 | Buy | $11.00 | +773.02% | Reiterates | a month ago |
Werewolf Therapeutics IncHOWL | 9 | Buy | $15.00 | +155.54% | Maintains | a month ago |
Day One Biopharmaceuticals IncDAWN | 6 | Buy | $50.00 | +217.46% | Reiterates | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.